Urgent.News

What's breaking now, across thousands of outlets.

Business

BoG Governor assures Ghanaians of Cedi stability ahead of Christmas

The Governor of the Bank of Ghana (BoG), Dr Johnson Asiama, has assured Ghanaians of relative stability in the exchange rate during the Christmas period, expressing confidence in the Cedi's performance.

BoG Governor assures Ghanaians of Cedi stability ahead of Christmas

Dr Johnson Asiama, Governor of the Bank of Ghana, has assured Ghanaian citizens of a stable exchange rate during the upcoming Christmas season. Expressing confidence in the Cedi's performance, he addressed concerns about exchange rate fluctuations and their effects on businesses, importers, and consumers. At the African Virtual Assets Summit (AVAS) 2026 on November 2, Dr Asiama offered the promise amid worries about currency movements.

"What I can promise is a good Christmas as far as the exchange rate is concerned. We will have a good Christmas," he stated. The latest interbank exchange rates from the Bank of Ghana indicated that one US dollar would yield GH¢11.6142 for buying and GH¢11.6258 for selling. The central bank's reference rates also showed that one pound sterling was equivalent to GH¢15.5549 for buying and GH¢15.5704 for selling, while one euro was exchanged for GH¢12.9559 for buying and GH¢12.9678 for selling.

Written by urgent.news from MyJoyOnline Ghana's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at myjoyonline.com →

More in Business

Samsung Biologics Secures Nearly 98% Stake in PolyPeptide

Samsung Biologics announced on Nov. 2 that it recorded a final subscribed stake of 97.98% in the tender offer for the global peptide contract development and manufacturing organization (CDMO) company ‘PolyPeptide Group’, satisfying not only the minimum acceptance condition for the transaction but al

  • Samsung Biologics acquired nearly 98% of PolyPeptide Group on November 2.
  • The transaction met the compulsory purchase threshold for minority shares.
  • Deal valued at 1.46 billion Swiss francs, expanding Samsung Biologics' peptide business.

More from Monday 2 November →